Charles River Laboratories Intl. (NYSE:CRL) Upgraded by Zacks Investment Research to Buy

0
40

Charles River Laboratories Intl. stock has undergone multiple analysts rating changes in the recent past.  Charles River Laboratories Intl. Upgraded by Zacks Investment Research on 7/2/2020. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

Shares of Charles River Laboratories Intl. traded up $1.52 on Thursday, reaching $176.92. 583159 shares of the stock traded hands, compared to its average volume of 405627. Shares of Charles River Laboratories Intl. closed trading at $176.92 on Thursday. The firm’s 50 day moving average is $167.56 and its 200 day moving average is $148.95.Charles River Laboratories Intl.  has a 12 month low of $174.82 and a 12 month high of $189.85. While on yearly highs and lows, Charles River Laboratories Intl.’s today has traded high as $177.70 and has touched $174.82 on the downward trend. See More Analyst Rating at: RATING

Charles River Laboratories Intl. Earnings and What to expect: 

Charles River Laboratories Intl. last announced its quarterly earnings results on May 7th, 2020. The medical research company reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.38. The business earned $707.06 million during the quarter, compared to the consensus estimate of $692.11 million. Its revenue was up 17.0% compared to the same quarter last year. Charles River Laboratories Intl. has generated $6.73 earnings per share over the last year and currently has a price-to-earnings ratio of 35.6. Charles River Laboratories Intl. has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, July 29th, 2020 based off prior year’s report dates.

Earnings for Charles River Laboratories Intl. are expected to grow by 20.20% in the coming year, from $6.88 to $8.27 per share. The P/E ratio of Charles River Laboratories Intl. is 35.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.72. The P/E ratio of Charles River Laboratories Intl. is 35.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.41. Charles River Laboratories Intl. has a PEG Ratio of 1.82. PEG Ratios above 1 indicate that a company could be overvalued. Charles River Laboratories Intl. has a P/B Ratio of 5.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 1.90%
  • On 5/22/2020 Director George Massaro Sell 941 at average share price of $173.40 which equates to $163,169.40 in money value.
  • On 5/20/2020 Director Robert J Bertolini Sell 3,530 at average price of  $174.58 with total value of : Not Data Available
  • On 5/12/2020 VP Birgit Girshick Sell 780 at average price of  $165.74 with total value of : $129,277.20

Analyst at Zacks Investment Research are also talking about :

  • 7/1/2020 – Charles River Laboratories Intl. was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. (View)
  • 7/1/2020 – Charles River Laboratories Intl. was upgraded by analysts at Bank of America Corp from a “neutral” rating to a “buy” rating. They now have a $192.00 price target on the stock. (View)
  • 7/1/2020 – Charles River Laboratories Intl. was upgraded by analysts at BofA Securities from a “neutral” rating to a “buy” rating. They now have a $192.00 price target on the stock. (View)
  • 6/15/2020 – Charles River Laboratories Intl. was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $201.00 price target on the stock. (View)

Charles River Laboratories Intl. (NYSE:CRL) Moving Average Technical Analysis

5 day Moving Average is $173.16 And 5 day price change is $3.32 (1.91%)  with average volume for 5 day average is 457,520. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $176.68 and 20 day price change is -$6.51 (-3.55%) and average 20 day moving volume is 423,400. 50 day moving average is $167.56  and 50 day price change is $39.80 ( 29.03%)  and with average volume for 50 days is : 389,698. 200 day moving average is $148.95  and 200 day price change is $42.57 (31.69%)  and with average volume for 200 days is : 395,760.

See More Analyst Rating at: RATING